Make a gift by December 2nd, 2025 to double your impact.
NET Survivor Finds Hope and Inspiration That’s it—my number is up, Dave McCoy thought when he learned he had neuroendocrine cancer in 2008. A cancer, he
Understanding the grade and stage of neuroendocrine cancer and how that relates to prognosis.
The U.S. Food and Drug Administration (FDA) approved iobenguane I 131, an intravenous radiotherapeutic, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or
Natural or man-made disasters often occur with little or no notice. Being prepared for a disaster during COVID-19 is important for everyone, but cancer patients
If you are having surgery for a NET tumor, consider donating some of your tumor tissue to help research. The Neuroendocrine Tumor Research Foundation is
Finding hope and motivation in a dark place, a young NET patient describes her life leading up and following peptide receptor radionuclide therapy (PRRT).
The Neuroendocrine Tumor Research Foundation (NETRF) has invested more than $1.5 million in advancing a precision form of radiation therapy for NETs called Peptide Receptor
Summer sun safety tips for cancer survivors. The signs and symptoms of heat-related illness.
by Stacie Chevrier, NET Cancer Blogger Every Sunday on the O Network’s Super Soul Sunday, Oprah asks her guest, “What do you know for sure?” This
Dispelling Myths about Palliative Care The goals of palliative care according to Steven Pantilat, MD, University of California, San Francisco, are pretty straightforward—to do as